Research & Innovation at the University Hospital (CHU) of Besançon
Clinical and translational research topics
Three strategic research modules defined in keeping with the national research and innovation strategy and in collaboration with the university of Franche-Comté.
This module focuses on a topic developed over several years by the CHU in collaboration with the Établissement Français du Sang Bourgogne Franche-Comté (French Blood Establishment of Bourgogne Franche-Comté), recognised with the creation of the Clinical Investigation Centre (CIC-BT) in 2005, now Inserm CIC 1431, and renewed in 2016. Along with UMR - UFC - Inserm 1098, they study the following topics:
- development and assessment of biotherapies in haematology-oncology,
- biotherapy and transplantation: cell, tissue and organ transplants,
- biotherapies for inflammatory diseases,
- human papillomavirus (HPV),
- medically assisted procreation (MAP).
RISQUES module: neuro-cardiovascular, infectious and environmental risks
This module focuses on vulnerabilities and risks and their interactions with social change. In cooperation with UMR - CNRS - UFC 6249 Chrono-environment and EA 3920, 481 and 4267, it includes:
- infectious & microbiological risks, including their environmental dimension,
- cardioneurovascular risks,
- addictions and high-risk behaviours,
- ethics and medical progress (with the “IT at the CIC” module),
- oriented toward vulnerability.
This module is based on Franche-Comté's unique story, its history in microtechnologies, the existence of a dedicated competitiveness centre, the development of the Femto-ST Institute (UMR CNRS - UFC - ENSEMM - UTBM 6174) and, at the CHU, the current Inserm CIC 1431 Clinical Investigation Centre (CIC-IT), accredited in 2008 and renewed in 2016:
- microsystems & biological qualifications,
- technologies for healthcare in neuropsychiatry,
- éthics & medical progress (with the ProMES module).
>> The Besançon university hospital also has a biological resource center